Photo of Marc-Aurel Fuchs

Marc-Aurel Fuchs

Mr

20132019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Marc-Aurel Fuchs is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 50 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 4 Article
  • 2 Conference contribution
  • 1 Meeting abstract

Evidence of somatic mitochondrial DNA mutations in primary open angle glaucoma: ARVO Annual Meeting Abstract

Vallabh, N. A., Lane, B., Simpson, D. A., Fuchs, M., Choudhary, A., Criddle, D., Cheeseman, R. & Willoughby, C., 01 Jul 2019, In : Investigative ophthalmology & visual science. 60, 9

Research output: Contribution to journalMeeting abstract

  • Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies

    Alvi, M., Loughrey, M. B., Dunne, P., McQuaid, S., Turkington, R., Fuchs, M-A., McGready, C., Bingham, V., Moore, W., Lawler, M., James, J. A., Murray, G. I., Wilson, R. H., Maxwell, P. & Salto-Tellez, M., 11 Jul 2017, In : British Journal of Cancer. 117, 2, p. 203-209

    Research output: Contribution to journalArticle

    Open Access
    File
  • 193 Downloads (Pure)

    Natural killer-like signature observed post therapy in locally advanced rectal cancer is a determinant of pathological response and improved survival

    Alderdice, M., Dunne, P. D., Cole, A. J., O'Reilly, P. G., McArt, D. G., Bingham, V., Fuchs, M-A., McQuaid, S., Loughrey, M. B., Graeme, M. I., Samuel, L. M., Lawler, M., Wilson, R. H., Salto-Tellez, M. & Coyle, V. M., 16 Jun 2017, In : Modern Pathology .

    Research output: Contribution to journalArticle

    Open Access
  • 6 Citations (Scopus)

    ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.

    Weir, J-A., Gilliland, P., Fuchs, M-A., Williams, R., Murray, L., Johnston, P. & Van Schaeybroeck, S., Nov 2016, ADAM17: a potential regulator of resistance to EGFR targeted therapies in RAS wild type colorectal cancer.. National Cancer Research Institute

    Research output: Chapter in Book/Report/Conference proceedingConference contribution

  • Validation of a MEK/MET-specific NGS panel for early phase trial interrogation

    Maxwell, P., del favero, J., Fuchs, M-A., Tabernero, J., Maughan, T., Middleton, M., Adams, R., Rolfo, C., Hennessy, B. T., Laurent=puig, P., Bardelli, A., Andre, T., Popovici, V., Johnston, P., Wilson, R., Lawler, M., Van Schaeybroeck, S. & Salto-Tellez, M., 01 May 2016, Validation of a MEK/MET-specific NGS panel for early phase trial interrogation . Proceedings: AACR Annual Meeting 2016; April 16-20 New Orleans, Vol. abstract 1396.

    Research output: Chapter in Book/Report/Conference proceedingConference contribution